At a glance
- Originator Merck & Co
- Class Antivirals; Nucleosides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 11 Aug 1998 No-Development-Reported for Cytomegalovirus infections in USA (Unknown route)